Aryna Sabalenka, Jessica Pegula back WTA’s new gender testing rule
The WTA has implemented a new genetic eligibility policy requiring players to undergo SRY gene testing, sparking a debate among top athletes. Aryna Sabalenka supports the policy as a measure for competitive fairness, while Jessica Pegula views it as a routine administrative update.
Why it matters
The policy highlights the ongoing tension in professional sports regarding biological eligibility criteria and the inclusion of transgender athletes.
Women's tennis rarely agrees on anything -- scheduling, prize money, the calendar. But the WTA's new genetic eligibility policy, which took effect July 21, has produced something unusual: near-silence from the locker room. No protests. No open revolt. What it has produced, though, is a revealing split between two of the tour's biggest names. World No. 1 Aryna Sabalenka sees the SRY gene test as a matter of principle. World No. 3 Jessica Pegula sees it as a bureaucratic update. Both reactions are worth examining.What did Aryna Sabalenka say about the WTA gender testing policy?Aryna Sabalenka addressed the policy at her pre-tournament press conference ahead of the National Bank Open in Toronto, making it clear she was not neutral on the subject."I think it's really important to keep the fairness in our tour," she said.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in